FINAL ROUND
Please consider taking part in this important study by ranking your top 7 recommendations for helping patients with alcohol related cirrhosis avoid a return to harmful drinking.
https://t.co/YrkK4ZT7LO
Thank you! Any RTs also greatly appreciated.
🆕Article in press❕
Plasma exchange does not improve overall survival in patients with acute liver failure in a real world cohort
Read it here👉https://t.co/esxohfrPIr
#LiverTwitter
Could you help us prevent relapse to alcohol for patients with advanced liver disease?
If you work in this area or are a patient or caregiver, please consider sharing your views by completing our short survey.
https://t.co/I31PRnYv6G
🟪NEW Article in press❕
Hepatocellular Carcinoma risk scores for non-viral liver disease: a systematic review and meta-analysis
🔓#OpenAccess at 👉 https://t.co/rQiP4Gb5hU
#LiverTwitter#HCC
🚨 For everyone providing care for patients with alcohol related liver disease 🚨
ALERT UK - a national audit of inpatient care is now open!
Find out more and register your site here: https://t.co/X6hJdU3eyL
We are delighted to endorse and share the Primary Biliary Cholangitis (PBC) Care Bundle for use in outpatient clinics to ensure that all relevant aspects of PBC management are addressed. Download it here 👇 https://t.co/tBwILc04PB
Read the paper by Parker et al entitled
"Quality standards for the management of alcohol-related liver disease: consensus recommendations from the @BASLedu and @BritSocGastro ARLD special interest group" via https://t.co/3wqIXOda7U
@DrStevenMasson@DrADhanda@liver_dietitian
Predicting the 5-year risk of clinical outcomes for people with #cirrhosis
Just re-read this Shearer / @IanARowe paper and it is very good. https://t.co/L5vphH3xyd
3000 patients. 3 years+. Countless informative statistics for counseling and decision making
#livertwitter
These consensus recommendations from the BASL/ BSG ArLD special interest group are intended to improve quality and reduce variation in the management of ArLD. Recommendations for all aspects of management of ArLD are provided, read the full article below: https://t.co/CKe50mts2r
Really enjoyed talking about testing for liver disease @LeedsHospitals and understanding how treatments might benefit patients with #NASH
Have a listen @surfing_NASH and let me know what you think
https://t.co/RS8ZkgW482
@LeedsMedHealth @MedicineDean